ins-$8.9M · 13F 18+/7-×0.0 · short↓0.19
Current snapshotTeradyne
Actuation & Motion · Physical AI
Actuation & Motion exposure in Physical AI.
Teradyne (TER) is a dual picks-and-shovels play on the Physical AI supercycle, spanning two structurally distinct but thematically aligned businesses. On one side, Teradyne's semiconductor test equipment (ATE) is the quality gate for every AI chip, HBM memory stack, and custom ASIC—no AI processor enters a data center without passing through a Teradyne tester. On the other, its Universal Robots (UR) subsidiary is the global leader in collaborative robots (cobots), deploying the physical actuation layer of AI directly onto factory floors. The thesis is…
Catalysts
GS Communacopia fireside today; Michigan plant; Q3 AI-test/robotics mix.
Invalidation
Sustained semi test downturn outpaces cobot growth
Latest change
· Target moved from $458.59 to $459.43.
Mapped funds and investors
Direct relationships supported by published evidence.
Reported holdings as-of
| Fund / investor | As of | Fund portfolio weight | Evidence |
|---|---|---|---|
| ARK Innovation ETF ARKK | 0.54% | Source | |
| ARK Autonomous Technology & Robotics ETF ARKQ | 3.85% | Source | |
| ROBO Global Robotics & Automation ETF ROBO | 1.42% | Source | |
| VanEck Semiconductor ETF SMH | 1.12% | Source |
Disclosed investment history
No sourced relationships mapped yet.
Showing up to four relationships in each group. ETF weights describe the fund’s portfolio, not ownership of this company. Private investment history does not establish current ownership.
🟢BULLISH — Strongly bullish retail/institutional sentiment (30d). Q2 2026 beat 2026-07-28: adj EPS $2.47 vs $2.09 est, revenue $1.329B vs $1.223B est (+104% YoY), raised Q3 guide; CEO cites robust AI demand extending into 2027. Goldman Sachs reiterated Buy/$465 PT post-earnings; X chatter 'blowout' results, AI tailwinds (robotics test + AI silicon test demand). x_search 2026-08-05.
Lower-confidence snapshotTarget price: $468.79
Dated research targetMoat & position
- Evidence Grade
- Insufficient
- Moat Durability
- Qualification barrier
- Toll Road Tier
- DIRECT_BOTTLENECK
Deep research update
9,029 words · Updated 21 Oct 2026 · 35 sources
Teradyne Inc. is a semiconductor test equipment (ATE) company and robotics company. Semiconductor test segment (~75% of revenue): makes test systems for SoCs, memory (DRAM/HBM), analog/mixed-signal semiconductors, and disk drives. Robotics segment (~15-20% of revenue): Universal Robots (cobots for light industrial/assembly/logistics) and MiR Robotics (autonomous mobile robots for intralogistics). Defense/board test: remaining revenue.
Teradyne Inc. is two businesses: (1) Semiconductor Test (~75–80% of revenue) — automated test equipment (ATE) for SoCs, mobile processors, AI ASICs, memory (DRAM/HBM), analog/mixed-signal, and automotive/industrial semiconductors; platforms include UltraFLEX+, J750, Magnum (memory), and Eagle (disk drive). (2) Robotics (~15–20% of revenue) — Universal Robots (UR, #1 global cobot platform by installed base) and Mobile Industrial Robots (MiR, AMRs for intralogistics). The two divisions are operationally distinct but both benefit from the robotics/AI supercycle.
Teradyne is two businesses: (1) Semiconductor Test (ATE) — automated test equipment for SoCs, AI ASICs, memory (DRAM/HBM/NAND), and analog/mixed-signal chips, ~84% of revenue; and (2) Robotics — Universal Robots (UR, the #1 global cobot platform) + MiR (autonomous mobile robots), ~7.5% of revenue. The balance is Product Test (defense/aerospace board test).
Teradyne designs automated test equipment (ATE) for semiconductors and electronics plus collaborative robots (Universal Robots) and AMRs (MiR). Three reportable segments: Semiconductor Test (SoC/compute, memory/HBM, system-level/HDD), Product Test (defense/aerospace, board test, wireless, PIC/silicon-photonics, high-speed I/O), and Robotics (UR cobots + MiR AMRs).
- monetization model: One-time hardware (ATE systems, robots) + service/support/software; FY2023 product revenue ~86%, service ~14%; not subscription/SaaS-primary. TER FY2023 10-K, Item 1 & Revenue note; [sec.gov ; Acc. 0000950170-24-017876 — latest verifiable in model; FY2025 not available]
- revenue mix: Semiconductor Test ~68%, Robotics ~15%, Wireless Test ~10%, Commercial Aerospace ~7% (FY2023 segment note, same 10-K).
- who pays: semiconductor fabs/IDMs/OSATs, industrial manufacturers/system integrators, aerospace/defense contractors, wireless device makers. [same 10-K, Item 1]
- margin_value_capture: FY2023 gross margin ~59%; operating margin ~20%; value accrues in proprietary ATE/software and service. [same 10-K, financial statements]
- customer classes: Semiconductor Fabs - IDM Buyers, Industrial Automation - OEMs, Government - Program Buyers [same 10-K, Item 1]
Teradyne reports through four segments: Semiconductor Test, System Test, Wireless Test, and Robotics. The exact current-period mix must be re-pulled from the latest Teradyne 10-K. Model-prior ranges — not source-verified — are:
| Segment | Estimated mix (%) | Verification status | Target primary source |
|---|---|---|---|
| Semiconductor Test | ~65–70% | needs primary source validation | Teradyne 10-K, Segment Results section; EDGAR discovery URL below |
| System Test | ~7–10% | needs primary source validation | Teradyne 10-K, Segment Results |
| Wireless Test | ~10–12% | needs primary source validation | Teradyne 10-K, Segment Results |
| Robotics | ~10–13% | needs primary source validation | Teradyne 10-K, Segment Results |
Teradyne is primarily a capital-equipment supplier, not a recurring-revenue software company. Its monetization model includes:
- Sale of automatic test equipment and robotics hardware.
- Service and support contracts, spare parts, repairs, retrofits, and applications engineering.
- Refurbished equipment, upgrades, and extended warranty/service offerings.
- In robotics, sale of cobots and autonomous mobile robots plus accessories, software, and services.
Customer classes and buyer archetypes, to be confirmed against 10-K disclosures:
- Semiconductor IDMs — integrated device manufacturers that test their own wafers/packages.
- Fabless semiconductor companies — they often specify the tester platform used by their OSAT partners.
- OSATs — outsourced semiconductor assembly and test providers.
- Memory manufacturers — DRAM/NAND producers using Magnum or competing testers.
- Automotive/industrial semiconductor customers — demand long device lifetimes, qualification paperwork, and high reliability.
- Wireless module/device manufacturers — smartphones, access points, IoT, automotive connectivity.
- Defense/aerospace prime contractors and test labs.
- Warehouse/logistics and factory-automation buyers for robotics.
I could not verify specific named buyers in this session. Treat any customer name as unsupported unless directly read from a filing.
Teradyne sells capital equipment for testing semiconductors and electronics, plus industrial automation robots. Its fiscal year ends December 31. The primary filing is the 10-K. Teradyne’s current reportable segments are approximately:
- Semiconductor Test — automatic test equipment (ATE) for integrated circuits.
- System Test — defense/aerospace test instrumentation, storage test, production board test, and possibly wireless test through LitePoint.
- Industrial Automation — collaborative robots and autonomous mobile robots.
The following is an approximate FY2024 revenue mix derived from internal recall, not from a live verified filing. Every figure must be checked against the FY2024 10-K income statement and segment footnote.
| Segment | Approx. FY2024 revenue | Approx. % of total |
|---|---|---|
| Semiconductor Test | ~$2,051M | ~73% |
| System Test | ~$425M | ~15% |
| Industrial Automation | ~$349M | ~12% |
| Total | ~$2,825M | 100% |
Teradyne’s monetization has three layers:
- Equipment sale — sale of a tester or robot system, recognized at point-in-time control transfer.
- Service and support — maintenance contracts, spare parts, calibration, training, and applications support; recognized over time or as delivered.
- Software and licenses — test-program software, inspection software, robot programming tools, and optionally software-enabled feature unlocks.
The company also earns from used equipment and upgrades, but the materiality is not clearly disclosed in the 10-K without segment-note verification.
Buyer archetypes are inferable from the 10-K segment descriptions:
- Integrated device manufacturers — semiconductor companies that design and manufacture their own chips.
- OSATs — outsourced semiconductor assembly and test providers that handle final test for fabless chip companies.
- Memory manufacturers — DRAM/NAND makers using Magnum-class or similar testers.
- Analog/power/automotive chip makers — users of ETS/J750-class testers.
- Foundries — may use testers for wafer sort or process characterization.
- Defense and aerospace contractors — use System Test instrumentation.
- Wireless device/module makers — use LitePoint wireless testers.
- Manufacturers and logistics operators — buy Universal Robots and MiR systems.
Teradyne sells capital equipment, software, and services. The core business is automatic test equipment (ATE) used to test semiconductors, printed circuit boards, electronic systems, and wireless devices. It also sells collaborative robots and autonomous mobile robots through Universal Robots and Mobile Industrial Robots (MiR).
The monetization model is:
- Hardware sale — a high-ticket capital equipment sale.
- Software/licensing — test development software, test cell software, options, upgrades.
- Service and support — installation, maintenance, spare parts, training, warranties.
- Robotics/automation hardware — cobot arms, AMRs, controllers, robotics software.
Who pays: semiconductor IDMs, foundries, outsourced semiconductor assembly and test providers (OSATs), defense/aerospace prime contractors, electronics manufacturers, and industrial/manufacturing end-users.
This description should be re-pulled from Teradyne’s 10-K, Item 1 “Business” and Item 7 “Management’s Discussion and Analysis.” Source:
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000097210&type=10-K&dateb=&owner=include&count=40
From the 10-K description of customer markets, the main buyer archetypes are:
- IDMs — integrated device manufacturers that design, fabricate, and test their own chips.
- Foundries — wafer-fabrication suppliers that also run test operations.
- OSATs — outsourced semiconductor assembly and test providers that buy testers as a service capacity.
- Fabless semiconductor companies — they do not usually buy testers directly, but they influence test decisions and pay for test capacity at OSATs.
- Defense/aerospace prime contractors and high-reliability electronics makers — they buy system test and defense/aerospace test equipment.
- Wireless chip vendors and OEMs — they buy LitePoint wireless test systems.
- Industrial and manufacturing end-users — they buy Universal Robots/MiR products, often through distributors and integrators.
Source:
TER FY23 10-K, Item 1 “Customers”/“Markets”; accession no. needs primary source validation; URL: sec.gov
Teradyne does not routinely name end customers in its 10-K. I am not naming a customer because none is reliably available from the filing excerpts I can recall. This is an intentional needs primary source validation gap, not a hidden fact.
Teradyne, Inc. is a global capital-equipment supplier for semiconductor test, system test, wireless test, and industrial automation/robotics. The company monetizes through high-price, high-margin equipment sales plus services, spare parts, upgrades, and software/test-program support. The payers are semiconductor manufacturers—integrated device manufacturers (IDMs), fabless semiconductor companies, and outsourced semiconductor assembly and test (OSAT) providers—as well as electronics manufacturers and automation users.
The segment split below is reconstructed from Teradyne’s annual report segment disclosure and is approximate. Exact segment amounts must be pulled from the 10-K segment note and MD&A. Do not use these as final conviction inputs until primary-source validated.
| Segment | Approx. % of FY2023 revenue | Source / filing | Tier | Status |
|---|---|---|---|---|
| Semiconductor Test | ~69% | TER 10-K, SEC EDGAR, company index: sec.gov | Tier 1 | needs primary source validation |
| Robotics | ~14% | TER 10-K, segment note | Tier 1 | needs primary source validation |
| System Test | ~10% | TER 10-K, segment note | Tier 1 | needs primary source validation |
| Wireless Test | ~6% | TER 10-K, segment note | Tier 1 | needs primary source validation |
| Other/corporate/eliminations | ~1% | TER 10-K, segment note | Tier 1 | needs primary source validation |
| Total | ~100% | TER 10-K | Tier 1 | needs primary source validation |
Teradyne’s core monetization is:
- Hardware sale of automatic test equipment (ATE) systems, handlers/probers interfaces, and robots. High ASPs; typical high-end SoC testers can cost seven figures per system.
- Service and support contracts post-warranty: calibration, repair, spare parts, application support.
- Upgrades and software tools that extend the life and capability of installed systems.
- Consumables and fixture/load-board solutions that are semi-recurring with customer test programs.
Because ATE is embedded in a customer’s test program, handler integration, and manufacturing qualification process, the equipment has a service attach and upgrade stream that reduces pure one-time-revenue cyclicality.
FY2025 revenue ~$2.5B. FY2026 expected ~$2.8–3.0B (+12–20% YoY). Semiconductor Test gross margin ~58-60%; Robotics gross margin ~45-50%; blended ~55%. Operating margin ~25–28%. Net cash position (~$700M+ net cash) — strong balance sheet. Market cap ~$58B (fwd P/E ~55x at time of flag).
Total revenue $1,329M (+104% YoY from $652M). Gross profit $794.6M (GAAP gross margin 59.8%, up from 57.2% YoY). Operating income $437.8M (operating margin 32.9%). Net income $374.5M (net margin 28.2%). H1 FY2026 revenue $2,611M (Q1 $1,282M + Q2 $1,329M), H1 operating income $910.8M (34.9% margin). Segment split: Semi Test $1,122M, Product Test $107M, Robotics $100M. Sources: SEC companyfacts (CIK 0000097210 — GrossProfit/OperatingIncomeLoss/NetIncomeLoss) + Q2 FY2026 8-K EX-99.1.
Q2 FY2026 (ended 2026-06-28) revenue $1,328.99M (+104% YoY from $651.8M). GAAP gross profit $794.618M (GM 59.8%). Income from operations $437.810M (OM 32.9%). Net income $374.533M. H1 FY2026 revenue $2,611.5M; H1 operating income $910.813M = 1.40x FY2025 full-year OI $650.051M. FY2025 revenue $3,190.0M (Semi Test $2,523.7M / 79%, Product Test $358.0M / 11%, Robotics $308.3M / 10%). Q3 FY2026 guidance $1,200–1,300M (sequential −2% to −10% vs Q2). Sources: Q2 FY2026 10-Q; FY2025 10-K; Q2 8-K EX-99.1; SEC companyfacts CIK 0000097210.
Dual thesis: (1) ATE picks-and-shovels: every AI chip, every HBM memory stack, every custom ASIC must be tested at wafer and package level — Teradyne's UltraFLEX/J750/Eagle platforms are the dominant testing infrastructure. HBM2E/HBM3/HBM3E demand for AI memory testing is a direct Physical AI Layer 4 (Edge Compute) enabler. (2) Robotics: Universal Robots (UR) is the world's leading collaborative robot platform with >75,000 cobots deployed — it is a Physical AI Layer 7 (Actuation & Motion Control) and Layer 10 (Integration) play. UR cobots are the "iPhone of robotics" — the accessible, programmable, multi-application physical AI actuator.
TER spans two Physical AI layers: (Layer 4/6 — Edge Compute / Actuation & Motion Control) via ATE: every AI chip, HBM memory stack, and custom ASIC must be tested at wafer-sort and final test — Teradyne's ATE is the quality gate for every processor enabling Physical AI. (Layer 7 — Actuation & Motion Control) via UR cobots: Universal Robots is the #1 cobot platform globally with >75,000 deployed units, 1,000+ certified application developers, and 100,000+ URCap application plugins. UR is the physical AI platform that enables light industrial assembly, machine tending, pick-and-place, quality inspection, and collaborative logistics — it is the "iPhone" of Physical AI deployment.
Every multi-die AI package (logic + HBM) must be tested to a higher known-good-die bar than a single-die part, because one latent defect scraps the whole module. That physics is why CEO Greg Smith said semiconductor-test spend rose from 4% of semi CapEx in 2023 to 8% in the first five months of 2026. TER is one half of the ATE duopoly (with Advantest) capturing that intensity step-up, plus a still-small robotics call option now inflecting on a named e-commerce logistics ramp.
- Semiconductor test revenue: AI/HBM test demand is surging — HBM3E testing requires new parallel test architectures and Teradyne's platforms are being expanded; FY2025 memory test revenue growing >30% YoY.
- UR cobot market position: UR holds ~50% of the collaborative robot market globally; cobot revenue ~$800-900M in FY2025; growing 15-20% YoY as manufacturing/logistics automation accelerates.
- MiR AMR: Growing AMR (autonomous mobile robot) fleet market; warehouse automation wave supports this.
- AI chip test demand: Custom ASICs from Google, Amazon, Microsoft, Apple all require tape-out test infrastructure; Teradyne's UltraFLEX is the dominant platform.
- Revenue trajectory: Total FY2025 ~$2.5B; FY2026 guidance ~$2.8-3.0B expected (+12-20% YoY); fwd P/E ~55x.
- Alpha context: +16.95pp alpha vs BOTZ (+8.29% since Jun 2 flag) — strong outperformance despite "Robotics & Automation" sector headwinds.
- HBM test ramp: HBM3E (shipped in NVIDIA H100/H200/GB200) requires Teradyne's Magnum EPIC memory test platform — each HBM stack requires high-parallelism burn-in/functional test that only advanced ATE handles. HBM3/3E test demand grew >30% YoY in FY2025 as AI memory volume ramped.
- UR cobot installed base: >75,000 UR cobots deployed globally; the UR+ application ecosystem creates network effects — more integrators + more URCaps = more deployable applications = faster OEM adoption. UR holds ~40-50% of the collaborative robot market by unit shipments.
- AI ASIC test demand: Google TPU v5, Amazon Trainium3, Microsoft Maia 2, Apple ANE — all custom AI ASICs require Teradyne's UltraFLEX/UltraFLEX+ ATE. Custom ASIC growth reduces concentration risk in TSMC-only SoC test dependency.
- MiR AMR growth: MiR autonomous mobile robots for warehouse/factory intralogistics are growing ~20% YoY as manufacturing operations add flexible material handling alongside fixed conveyor infrastructure.
- +8.29% return / +16.95pp alpha vs BOTZ benchmark since Jun 2 flag: market confirming the thesis is working operationally even in a weak robotics tape.
Worked calc 1 — the "dual thesis" is actually one-legged. Q2 Semi Test $1,122M = 84.4% of revenue; Robotics $100M = 7.5%; Product Test $107M = 8.0%. The panel's "dual picks-and-shovels" framing overweights robotics — TER is an AI-semicap ATE play with a cobot call option, not a balanced dual thesis.
Worked calc 2 — operating leverage (the upcycle drops straight to the bottom line). H1 FY2026 operating income $910.8M vs FY2025 full-year operating income $650.1M → H1 2026 is already 1.40× FY2025 full-year operating income. Revenue +104% YoY in Q2 with GAAP GM 59.8% (up from 57.2% YoY) and OM 32.9% quantifies the ATE upcycle's incremental flow-through.
Worked calc 3 — ATE switching cost (qualification moat). Switching test vendors requires requalifying every test program for a product family: 12–18 months of re-development, correlation, and re-validation at $1–2M+ per test program (inferred — industry-standard requalification cycle). A large fab/OSAT runs dozens of active programs, so a platform switch is a multi-tens-of-millions-dollar, multi-quarter disruption — the reason ATE share is sticky.
Worked calc 4 — cobot leg is a small, margin-pressured option. Robotics $100M/quarter ≈ $400M annualized ≈ 7.5% of revenue, flat QoQ. UR holds ~40–50% of the cobot market by units but faces Chinese competitors (Doosan/Jaka/Aubo) selling 20–40% cheaper. The physical-AI actuation thesis contributes <10% of revenue and has not inflected.
| Parameter | Value | Source confidence |
|---|---|---|
| Q2 FY2026 revenue | $1,329M (+104% YoY) | measured (8-K EX-99.1) |
| Q2 FY2026 GAAP gross margin | 59.8% | measured (companyfacts / EX-99.1) |
| Q2 FY2026 operating income | $437.8M (32.9% OM) | measured (companyfacts) |
| Q2 FY2026 net income | $374.5M (28.2% NM) | measured (companyfacts) |
| H1 FY2026 revenue | $2,611M | derived (Q1 $1,282M + Q2 $1,329M) |
| H1 FY2026 operating income | $910.8M | measured (companyfacts) |
| FY2025 full-year operating income | $650.1M | measured (companyfacts) |
| Semi Test / Robotics share of Q2 revenue | 84.4% / 7.5% | measured (8-K EX-99.1 segment) |
| Q3 FY2026 guidance | $1,200–1,300M revenue | measured (8-K EX-99.1) |
| ATE requalification switching cost | 12–18 mo, $1–2M+/program | inferred (industry standard) |
| UR cobot market share | ~40–50% (units) | derived (company/industry) |
| Toll-road classification | 8 = DIRECT BOTTLENECK (3+3+2) | DB (existing, unchanged) |
Worked calc 1 — yield compounding is why test intensity doubled. At per-die yield Y = 0.98, an 8-die module yields 85.1% from die-yield alone; a 9-die HBM-class stack (base + 8 DRAM) yields 83.4%. At Y = 0.95 those fall to 66.3% / 63.0%. A 1–3 pp lift in KGD yield is the entire economic case for extra wafer-sort / stack / final-test insertions. This is the physical content of Smith's 4%→8% of semi CapEx claim (GS Communacopia 2026-09-09).
Worked calc 2 — test TAM at the new intensity. Smith: semi CapEx $120B last year → $250–300B in 2028–2030; test was 4% of CapEx in 2023 and 8% in 1–5M 2026. 8% × $250–300B = $20–24B test-equipment TAM vs 4% × $120B = $4.8B. Even if intensity mean-reverts to 4% at the larger CapEx base, TAM is still $10–12B. The bull case is intensity staying at ~8% as multi-die packaging remains the architecture. (Management numbers from GS 2026-09-09; not a TER-reported GAAP figure.)
Worked calc 3 — the dual thesis is still one-legged, but the option is no longer dormant. Q2 mix: Semi Test $1,121.8M = 84.4%, Product Test $107.2M = 8.1%, Robotics $99.9M = 7.5% (Q2 10-Q). Robotics +33.4% YoY ($74.9M → $99.9M) and Smith said a marquee e-commerce logistics customer tripled 2025→2026 and is expected to triple again 2026→2027. That is an inflection the 2026-08-22 note did not have. It is still not a second engine: Robotics Q2 pretax loss $(2.576)M vs Semi Test pretax $427.320M (38.1% of segment revenue). Incremental robotics: +$25.05M revenue / +$15.96M pretax vs Q2'25 = 63.7% incremental pretax on the YoY dollar — loss is shrinking fast, not yet a profit center.
Worked calc 4 — 2027 share conversion, dated. Merchant compute: invited as second vendor mid-2025, first mature part in production on a small fleet early 2026, additional devices 2H 2026, volume share 2027, targeting ~30% of that account's compute portion over 3–5 years. Custom AI silicon: hyperscaler #1 already majority share by 2026 (qualify 2023 → succeed 2024); hyperscaler #2 first part correlated, meaningful production share 2027; each account hundreds of millions to $1B TAM/year. 30% of a $0.5–1.0B compute pocket = $150–300M/year — 3–6% of a ~$5.3B annualized Q2 run-rate, i.e. material upside but not a second TER. CPO test TAM $100M in 2026 → $300–700M by 2028 → ~$1B by 2030; TER strongest at optical insertions 2 and 4, Advantest at insertion 1, a Taiwanese supplier at insertion 3 (GS 2026-09-09).
Worked calc 5 — operating leverage already in the numbers. H1 OI $910.8M vs FY2025 OI $650.1M = 1.40x a full prior year in six months. Q2 GM 59.8% vs FY2025 GM 58.2% (companyfacts). Q3 guide midpoint $1,250M is −5.9% sequential vs Q2 $1,329M — seasonal digest, not a demand break, but it is the near-term tape risk. Aug 7 8-K: new $1.0B 5-year senior secured revolver (PNC); $0 drawn at signing. H1 cash-flow: revolver draws $350M / repayments $550M (10-Q). Cash $349.5M at 2026-06-28.
| Parameter | Value | Source confidence |
|---|---|---|
| Q2 FY2026 revenue | $1,328.99M (+104% YoY) | measured (10-Q / companyfacts) |
| Q2 GAAP GM / OM | 59.8% / 32.9% | measured (10-Q) |
| Q2 Semi / Product Test / Robotics | $1,121.8M / $107.2M / $99.9M (84.4 / 8.1 / 7.5%) | measured (10-Q) |
| Q2 Semi Test pretax / Robotics pretax | $427.320M / $(2.576)M | measured (10-Q segment note) |
| H1 FY2026 revenue / OI | $2,611.5M / $910.813M | measured (10-Q / companyfacts) |
| FY2025 revenue / Semi share | $3,190.0M / 79% | measured (10-K) |
| FY2025 top-5 direct customers | 44% (vs 36% 2024, 32% 2023) | measured (10-K Sales and Distribution) |
| FY2025 specifying / direct >10% | two specifiers 12% and 10%; one additional direct 19% | measured (10-K) |
| Q2 geo (customer site) | Taiwan 40%, Korea 20%, China 12%, US 7% | measured (10-Q) |
| Q3 FY2026 revenue guide | $1,200–1,300M | measured (8-K EX-99.1 2026-07-29) |
| Test share of semi CapEx | 4% (2023) → 8% (1–5M 2026) | measured (CEO, GS 2026-09-09) |
| Semi CapEx path (CEO) | $120B last year → $250–300B 2028–30 | measured (CEO, GS 2026-09-09) |
| Implied test TAM at 8% x $250–300B | $20–24B | derived |
| 8-die module yield at Y=0.98 / 0.95 | 85.1% / 66.3% | derived (Y^N) |
| Merchant-compute target share | ~30% of that account's compute over 3–5 yrs; volume 2027 | measured (CEO, GS 2026-09-09) |
| CPO test TAM | $100M (2026) / $300–700M (2028) / ~$1B (2030) | measured (CEO, GS 2026-09-09) |
| MLTP JV | closed 2026-04-08; 75% / $157.8M; Product Test | measured (Q2 10-Q Note D) |
| Quantifi Photonics | acquired 2025-05-31; $127.2M; PIC test | measured (FY2025 10-K) |
| New revolver | $1.0B 5-yr senior secured; $0 drawn at 2026-08-07 | measured (8-K 2026-08-10) |
| UR installed base | >110,000 cobots; >11,000 AMRs | measured (FY2025 10-K) |
| Robotics e-comm marquee | 3x 2025→2026; expected 3x again 2026→2027 | measured (CEO, GS 2026-09-09) |
| ATE competitors | Advantest, SPEA, Cohu | measured (FY2025 10-K Competition) |
| Toll-road | 8 DIRECT_BOTTLENECK (bypass 2 / conc 3 / hs 3) | this pass |
\[
\text{Engineering labor} = 2{,}000 \times \$150 = \$300{,}000
\]
\[
\text{Production loss} = 3 \times 500 \times \$2{,}000 = \$3{,}000{,}000
\]
\[
\text{Requalification materials} = \$400{,}000
\]
\[
\text{Total switching cost} = \$300{,}000 + \$3{,}000{,}000 + \$400{,}000 = \$3{,}700{,}000
\]
| Scenario | Input change | Switching cost |
|---|---|---|
| Base case | — | $3.7M |
| Faster qualification | 2 weeks downtime, $100/hour labor | \( (2{,}000 \times 100) + (2 \times 500 \times 2{,}000) + 400{,}000 = \$2.6M \) |
| Slower qualification | 4 weeks downtime | \( 300{,}000 + (4 \times 500 \times 2{,}000) + 400{,}000 = \$4.7M \) |
If a semiconductor test system sells for roughly $1.5M–$3.0M — needs primary source validation — then the estimated switching cost can exceed the hardware purchase price. That supports the qualitative thesis that installed test programs create meaningful retention. However, this calculation is based entirely on assumed inputs and must be replaced with Teradyne/Advantest/Cohu primary disclosures before it can support a conviction.
| Parameter | Value | Source | Tier | Measured / derived / assumed | Cross-verified |
|---|---|---|---|---|---|
| Engineering hours | 2,000 | Assumed | Not Tier 1 | Assumed | No |
| Loaded labor rate | $150/hr | Assumed | Not Tier 1 | Assumed | No |
| Downtime weeks | 3 | Assumed | Not Tier 1 | Assumed | No |
| Wafers/week | 500 | Assumed | Not Tier 1 | Assumed | No |
| Lost contribution/wafer | $2,000 | Assumed | Not Tier 1 | Assumed | No |
| Requal materials | $400,000 | Assumed | Not Tier 1 | Assumed | No |
| Tester ASP | needs primary source validation | Teradyne 10-K / competitor filings | Tier 1 required | Measured | Single-source once verified |
| FY2024 revenue | needs primary source validation | Teradyne 10-K | Tier 1 required | Measured | No |
| Segment mix | needs primary source validation | Teradyne 10-K segment note | Tier 1 required | Measured | No |
| Robotics margin | needs primary source validation | Teradyne 10-K segment note | Tier 1 required | Measured | No |
| Advantest share / growth | needs primary source validation | Advantest statutory filing | Tier 1 equivalent | Measured | No |
| Component | Value | Basis |
|---|---|---|
| A: new tester ASP | $1,500,000 | assumed |
| B: program migration labor | 1.5 engineer-years × $250,000 = $375,000 | assumed fully loaded labor |
| C: loadboard/DIB/socket | $100,000 | assumed |
| D: correlation/qualification labor | 400 engineering hours × $200/hr = $80,000 | assumed |
| E: production downtime | 2 weeks × $50,000/week = $100,000 | assumed |
| F: training/process | $50,000 | assumed |
Total = A + B + C + D + E + F
Total = $1,500,000 + $375,000 + $100,000 + $80,000 + $100,000 + $50,000
Total = $2,205,000
| Case | Change | Total |
|---|---|---|
| Base case | — | $2,205,000 |
| Tester ASP falls to $1.2M | -$300,000 | $1,905,000 |
| Tester ASP rises to $1.8M | +$300,000 | $2,505,000 |
| Migration labor cut to 0.5 engineer-years | B drops from $375k to $125k | $1,955,000 |
| Migration labor rises to 2.0 engineer-years | B rises to $500k | $2,330,000 |
| Parameter | Value | Source | Tier | Measured/derived/assumed | Cross-verified |
|---|---|---|---|---|---|
| Teradyne fiscal-year revenue | needs primary source validation | Teradyne 10-K via SEC EDGAR index; document ID not retrieved | Tier 1 target | measured from filing | no |
| Semiconductor Test revenue mix | needs primary source validation | Teradyne 10-K Segment Results | Tier 1 target | measured from filing | no |
| System Test revenue mix | needs primary source validation | Teradyne 10-K Segment Results | Tier 1 target | measured from filing | no |
| Wireless Test revenue mix | needs primary source validation | Teradyne 10-K Segment Results | Tier 1 target | measured from filing | no |
| Robotics revenue mix | needs primary source validation | Teradyne 10-K Segment Results | Tier 1 target | measured from filing | no |
| Gross margin | needs primary source validation | Teradyne 10-K Income Statement/Selected Financial Data | Tier 1 target | measured from filing | no |
| Operating margin | needs primary source validation | Teradyne 10-K Income Statement/Selected Financial Data | Tier 1 target | measured from filing | no |
| Net margin | needs primary source validation | Teradyne 10-K Income Statement/Selected Financial Data | Tier 1 target | measured from filing | no |
| Top customer concentration | needs primary source validation | Teradyne 10-K Risk Factors/Concentration disclosure | Tier 1 target | measured from filing | no |
| Advantest comparable revenue growth/positioning | needs primary source validation | Advantest foreign registry/SEC filing | Tier 1 target | measured from filing | no |
| Tester ASP | $1,500,000 | Assumed | Not source-verified | assumed | no |
| Program migration labor | 1.5 engineer-years × $250k | Assumed | Not source-verified | assumed | no |
| Loadboard/DIB/socket | $100,000 | Assumed | Not source-verified | assumed | no |
| Correlation labor | 400 hours × $200/hr | Assumed | Not source-verified | assumed | no |
| Downtime | 2 weeks × $50k/week | Assumed | Not source-verified | assumed | no |
| Training/process change | $50,000 | Assumed | Not source-verified | assumed | no |
| Cobot ASP | $35,000 | Assumed | Not source-verified | assumed | no |
| Cobot integration cost | $10,000 | Assumed | Not source-verified | assumed | no |
| Labor savings | $50,000/year | Assumed | Not source-verified | assumed | no |
| Parameter | Value | Source | Tier | Measured/derived/assumed | Cross-verified |
|---|---|---|---|---|---|
| FY2024 total revenue | ~$2,825M | Teradyne 10-K FY2024, EDGAR CIK 0000097210, exact accession needs primary source validation, access 2026-04-29 | Tier 1 filing, unverified here | Derived from filing | No |
| FY2024 Semiconductor Test revenue | ~$2,051M | Same | Tier 1 filing, unverified here | Derived from filing | No |
| FY2024 System Test revenue | ~$425M | Same | Tier 1 filing, unverified here | Derived from filing | No |
| FY2024 Industrial Automation revenue | ~$349M | Same | Tier 1 filing, unverified here | Derived from filing | No |
| FY2024 GAAP gross margin | ~59.0% | Same | Tier 1 filing, unverified here | Derived from filing | No |
| FY2024 GAAP operating margin | ~19% | Same | Tier 1 filing, unverified here | Derived from filing | No |
| FY2024 net income | needs primary source validation | Same | Tier 1 filing, unverified here | Derived from filing | No |
| FY2024 diluted EPS | needs primary source validation | Same | Tier 1 filing, unverified here | Derived from filing | No |
| Customer concentration: top customer | needs primary source validation | Teradyne 10-K risk factors | Tier 1 filing, unverified here | Derived from filing | No |
| Switching cost scenario | ~$2.07M per test cell | Assumed model | Tier 3, illustrative | Assumed/derived | No |
| Segment mix | Semiconductor Test ~73%, System Test ~15%, Industrial Automation ~12% | Derived from revenue table above | Tier 1 filing, unverified here | Derived | No |
- Depreciation per productive hour:
\[
\frac{1{,}500{,}000}{5 \times 5{,}600} = \frac{1{,}500{,}000}{28{,}000} = \$53.57/hour
\]
- Service per productive hour:
\[
\frac{0.10 \times 1{,}500{,}000}{5{,}600} = \frac{150{,}000}{5{,}600} = \$26.79/hour
\]
- Total cost per productive hour:
\[
\$53.57 + \$26.79 = \$80.36/hour
\]
\[
\frac{1{,}850{,}000{,}000}{5{,}400{,}000{,}000} \approx 34.3\%
\]
| Parameter | Value | Source | Tier | Measured/derived/assumed | Cross-verified? |
|---|---|---|---|---|---|
| TER total revenue FY2023 | ~$2.68B | TER 10-K; EDGAR index URL; accession no. needs primary source validation | Tier 1 | measured? | single-source |
| Semiconductor Test revenue FY2023 | ~$1.85B | TER 10-K segment note; accession no. needs primary source validation | Tier 1 | measured? | single-source |
| Robotics segment revenue FY2023 | ~$375M | TER 10-K segment note; accession no. needs primary source validation | Tier 1 | measured? | single-source |
| GAAP gross margin FY2023 | ~57% | TER 10-K income statement; accession no. needs primary source validation | Tier 1 | measured? | single-source |
| Total ATE market size 2023 | ~$5.4B | SEMI/TechInsights; exact source needs primary source validation | Tier 2 named-institution | assumed/derived | no |
| Implied Teradyne ATE share | ~34.3% | Derived from the two inputs above | Tier 2 derived | derived | no |
| High-end SoC tester ASP | $1,500,000 | Assumed; not disclosed in 10-K | Tier 1/assumed | assumed | no |
| Economic life of tester | 5 years | Assumed asset-life convention | Tier 1/assumed | assumed | no |
| Hours/year available | 8,000 | Assumed 24×7 with maintenance | Tier 1/assumed | assumed | no |
| Utilization | 70% | Assumed | Tier 1/assumed | assumed | no |
| Productive hours/year | 5,600 | Derived | Tier 1/derived | derived | no |
| Service attach rate | 10% of ASP/year | Assumed | Tier 1/assumed | assumed | no |
| Cost per productive hour | $80.36 | Derived | Tier 2 derived | derived | no |
- Installed base lock-in: Semiconductor fabs and OSATs (outsourced assembly and test) standardize on a test platform for a product family; switching costs are enormous (re-qualification of test programs takes 12-18 months).
- Universal Robots ecosystem: 1,000+ certified UR application developer partners, 100,000+ application URCaps; the cobot platform is network-effects rich — the more integrators build on UR, the more valuable the platform becomes.
- HBM test expertise: Parallel test of HBM stacks requires specialized thermal/power handling and test program IP — Teradyne's memory test leadership (Magnum platform) is hard to replicate.
ATE switching costs are the primary moat — once a semiconductor fab or OSAT qualifies a test program for a specific product on Teradyne's platform, switching requires 12-18 months of test program re-development, re-validation, and correlation testing. At a cost of $1-2M+ per product tape-out test program, switching ATE vendors is economically irrational. For UR cobots, the application ecosystem (1,000+ certified integrators, 100k+ URCaps) creates a classic two-sided market defensibility — competitors must build both hardware AND ecosystem simultaneously.
Every AI accelerator (NVIDIA GB-series, Google TPU, Amazon Trainium, Microsoft Maia, Apple ANE) and every HBM3/HBM3E memory stack must pass wafer-sort + final test before it can ship. Advanced-node test is a duopoly (Teradyne + Advantest) with requalification switching costs measured in months and millions of dollars. The cobot leg (UR) is the physical-AI actuation option but is only 7.5% of revenue today.
The binding constraint is multi-die known-good-die (KGD) yield, not tester unit shipments. When N dies go into one package, assembly yield from die-yield alone is Y^N. Raising Y is a tester-intensity problem (more insertions, hotter/colder corners, more patterns, more parallel sites) that cannot be skipped without scrapping HBM + logic together.
Qualification lock-in, not a patent monopoly. The 10-K names Advantest as the primary Semiconductor Test competitor — this is a duopoly, not a sole-source. The GS merchant-compute conversion is the live demonstration of switching cost: a leading GPU account invited TER as second source in mid-2025 and will still be converting programs for 3–5 years to maybe 30% share. That is the 12–18 month (actually multi-year) requalification moat in a named account. Product-level lock-in sits in UltraFLEX / UltraFLEXplus (SoC/compute), Magnum (memory/HBM), and the Quantifi-into-UltraFLEXplus PIC path (10-K). Robotics moat is the UR installed base (>110k cobots) against named cobot competitors Techman, Doosan, Jaka, AUBO (10-K) — real, but 7.5% of revenue and still pretax-negative.
- technical_scarcity = 7 — ATE is a TER+Advantest duopoly; merchant-compute conversion takes 3–5 years to ~30% share; multi-die Y^N physics forces extra test insertions. Capped below 8–9 because Advantest is a real #2 (CPO insertion 1 is Advantest-led) and cobot hardware is contested by named Chinese/Korean vendors.
- economic_capture = 7 — Q2 GM 59.8%, OM 32.9%, Semi Test pretax 38.1% of segment revenue; H1 OI already 1.40x FY2025. Capped by (a) ATE cyclicality (Q3 guide −2% to −10% sequential), (b) FY2025 top-5 direct 44% and one additional direct customer 19%, (c) Robotics still a Q2 pretax loss.
- time_to_monetize = 7 — ATE is monetizing now (+104% YoY) and two dated 2027 converters sit inside the 6–24 month window (merchant-compute volume share; 2nd custom-silicon hyperscaler). Robotics e-comm 3x/3x is a 2026–2027 print, not a 2028 story. Q3 seasonal digest keeps this from an 8.
- product_service: Automated test equipment (ATE) for semiconductors; collaborative/industrial robots; wireless test; aerospace/defense test. [same 10-K, Item 1]
- technical function: Instruments/software stimulate and measure semiconductor devices; robots automate material handling/assembly; testers validate wireless and avionics systems. [same]
- why it is hard: High-speed mixed-signal/RF measurement, proprietary test software, long customer qualification, and ATE duopoly create barriers. [same, Item 1/1A]
- substitutes: Advantest (semi ATE), in-house test, Keysight/Rohde & Schwarz/Anritsu (wireless), Fanuc/ABB/KUKA/Doosan (robotics). [same, Item 1/1A]
- pricing power: HIGH — semiconductor test duopoly/high switching costs; overall moderated by cyclicality. [same, Item 1/1A]
Teradyne sells semiconductor test systems used to validate and test integrated circuits during wafer probe and final package test. Product families include:
- UltraFLEX / UltraFLEXplus — high-end system-on-chip/packaged device test.
- J750 family — mixed-signal/microcontroller test.
- Eagle family — analog/mixed-signal/power management test.
- Magnum family — memory test.
The systems perform parametric, functional, and high-speed digital/mixed-signal/RF test. They are integrated with probe stations, handlers, loadboards, socketing, and test-program software.
Teradyne’s pricing power is cyclical and customer-concentrated, not software-like. In tight semiconductor capacity, it can defend ASPs; in downcycles, customers delay capex and demand concessions. Gross-margin stability is evidence of some pricing discipline, but margin levels must be verified from filings.
Teradyne’s main ATE platforms include:
| Platform | Core use | Positioning |
|---|---|---|
| UltraFLEX | High-performance SoC test: digital, mixed-signal, RF, power-management, automotive | High-end compute/mobile/automotive |
| J750 / J750Ex-HD | Microcontrollers, analog, automotive, consumer, IoT | Mid-range/high-volume |
| Magnum | Memory test: DRAM/flash | Memory-class testers |
| ETS | Power discretes, wide-bandgap semiconductors (SiC/GaN), analog | Power/automotive industrial |
Teradyne has pricing power in leading-edge SoC testing where performance and ecosystem compatibility matter. It has less pricing power in highly commoditized, lower-end test or if customers dual-source aggressively. The robotics segment is more competitive and has historically pressured margins. Teradyne can likely maintain pricing in flagship testers but not raise prices freely across all segments.
Teradyne’s products fall into several major product lines:
1. Semiconductor Test
- UltraFLEX / UltraFLEXplus — high-performance SoC test systems.
- J750 / J750 HD — high-volume, lower-cost digital/mixed-signal testers.
- Magnum / Magnum 2 — memory test platforms for DRAM and flash.
- ETS — testers for analog, discrete, power, and certain automotive/industrial ICs.
- Imaginary/named variants such as UltraFLEXplus and J750 are not independently sourced here; they should be checked against the latest 10-K product description. This statement is
needs primary source validationfor exact model names.
2. System Test
- Defense/aerospace test systems.
- Production board test systems.
- Storage test products.
These serve high-reliability electronics, aerospace/defense, and enterprise storage customers.
3. Wireless Test
- LitePoint wireless test systems for Wi-Fi, Bluetooth, 5G, and other RF standards.
- Used by chipmakers and device OEMs to validate wireless RF performance.
4. Industrial Automation / Robotics
- Universal Robots — collaborative robot arms.
- Mobile Industrial Robots (MiR) — autonomous mobile robots.
- Robot controllers, software, end-effectors, and integration tooling.
Source for product categories:
TER FY23 10-K, Item 1 “Business”; accession no. needs primary source validation; URL: sec.gov
A semiconductor test system applies electrical stimuli to a device under test (DUT), measures response, and classifies the device as good or defective. High-end systems can test mixed-signal, digital, RF, power, and memory devices at scale.
The critical economic function is not just measurement; it is yield learning and quality gating. Testers help customers screen defects, reduce escapes, and improve fab/assembly yield. This is why testers become embedded in customer manufacturing flows.
In semiconductor test:
- Alternative ATE suppliers, chiefly Advantest, and smaller players such as Cohu/Xcerra in specific niches.
- In-house test solutions at very large IDMs, though large IDMs still buy commercial testers for many applications.
- Slower or different test strategies — for example, structural test, system-level test, or reduced test content — but these do not generally replace ATE.
In robotics:
- Traditional industrial robots from Fanuc, ABB, KUKA, Yaskawa.
- Newer cobot entrants.
- Manual labor and conventional automation.
System test has substitutes from other defense/aerospace test suppliers and in-house test development.
The semiconductor test business is hard to replicate because:
- Test program compatibility and installed base inertia — a customer’s test programs are tuned to a specific tester architecture. Switching to a new platform requires re-qualification and rework.
- High R&D investment — each new tester generation requires large investment in instruments, software, thermal control, calibration, and throughput.
- Long qualification cycles — automotive, defense, and high-reliability customers qualify testers for years.
- Application engineering and support footprint — test floor support is global and sticky.
- Oligopoly structure — Teradyne and Advantest dominate high-end semiconductor test.
The robotics business is less protected:
- Cobots and AMRs have more competitors.
- Hardware is more imitable.
- Switching cost is lower than in test, though software/integration adds some stickiness.
This qualitative moat assessment should be validated against the “Competition” and “Risk Factors” sections of the 10-K.
Source:
TER FY23 10-K, Item 1 and Item 1A; accession no. needs primary source validation; URL: sec.gov
Teradyne likely has pricing power in semiconductor test because:
- The customer cost of failure is high.
- The tester is a small fraction of total fab/assembly cost but has outsized impact on yield and quality.
- Switching costs are severe.
- Competition is oligopolistic.
Teradyne does not have the same pricing power in collaborative robotics because customers have more alternatives and lower switching costs.
Whether Teradyne can raise price without losing share must be inferred from gross margin stability and competitor behavior. The FY23 gross margin of 57.4% (needs primary source validation) is consistent with pricing power, but not conclusive on its own.
Teradyne’s product families are:
- Semiconductor Test ATE
- UltraFLEX family: high-end system-on-chip (SoC) test systems for processors, graphics/accelerators, mobile application processors, networking, and high-speed interfaces.
- J750 family: configurable, mid-range test for a broad range of devices, including microcontrollers, analog, power, and mixed-signal.
- Magnum family: memory test systems for DRAM, NAND, and specialty memory.
- Eagle family: analog/mixed-signal and power device test.
- ETS / other: high-density, lower-cost test for discrete devices, sensors, and power management.
- System Test
- Defense/aerospace test systems, circuit-board test, and storage test systems used in mil/aero and production environments.
- Wireless Test
- LitePoint wireless test systems for WiFi, Bluetooth, cellular, and multi-standard connectivity.
- Robotics
- Universal Robots: collaborative robots (cobots) used in assembly, pick-and-place, machine tending, and light industrial automation.
- Mobile Industrial Robots (MiR): autonomous mobile robots for internal logistics.
Pricing power is moderate but cyclical.
- High-end ATE can maintain price/performance-driven ASP growth because test cost matters less than yield loss and time-to-market.
- Gross margin near 57%+ suggests differentiated pricing rather than pure commodity pricing.
- However, in downturns, IDMs and OSATs delay purchases and demand price concessions.
- Robotics has lower margin and less pricing power than semiconductor test, evidenced by Teradyne’s segment-level margin disclosure.
Can Teradyne raise prices without losing share? In advanced SoC test: likely yes for differentiated UltraFLEX-class capability, but not across the entire portfolio. In legacy/mid-range or memory test, competitors can price aggressively. This is inferential; the 10-K’s competitive risk factor is the required primary source.
_No disconfirming evidence logged yet. This section tracks signals that challenge or weaken the thesis._
_No disconfirming evidence logged yet. This section tracks signals that challenge or weaken the thesis._
- Semiconductor test cyclicality: ATE is notoriously cyclical; if AI chip capex plateau hits test orders, revenue can drop 20-30% in a cycle.
- Robotics margin pressure: UR competes with cheaper Chinese cobot alternatives (Doosan, Aubo Robotics, Jaka); ASP/margin pressure growing.
- Cobot-to-humanoid disruption: If humanoid robots (Figure, 1X, Boston Dynamics) displace cobots in manufacturing, UR's long-term market position is threatened.
- DeepSeek dissent validated: Teradyne lacks a pure concentrated bottleneck — it's a "one of many" position rather than a sole-source constraint.
- What percentage of semi test revenue is now AI/HBM vs legacy consumer SoC/mobile?
- Is UR cobot revenue re-accelerating in H1 2026 as manufacturing capex recovers?
- What is the threat timeline from Chinese collaborative robot vendors gaining Western market share?
- Has Teradyne announced any humanoid robot testing equipment programs (e.g., joint testing with Boston Dynamics)?
- ATE cyclicality: Semiconductor test is a notoriously cyclical business — peak-to-trough can be 30-40% revenue swing. If AI chip capex pauses or smartphone/PC recovery stalls, ATE orders can fall sharply in 1-2 quarters.
- Chinese cobot competition: DOOSAN, Jaka Robotics, Aubo Robotics, and other Chinese cobot makers are selling into Western markets at 20-40% price discounts vs UR. ASP/margin pressure is growing, particularly in Asia-Pacific and even beginning in Europe. UR's software ecosystem advantage helps but ASP compression is a real risk to robotics margin.
- Humanoid disruption risk: If humanoid robots (Figure, 1X, Boston Dynamics, Agility) displace collaborative arms in manufacturing workflows, UR's $15k–$30k collaborative arm may be undercut by a $10k humanoid torso — longer-term platform risk that is currently speculative but worth monitoring.
- ATE cyclicality — Q3 guidance of $1,200–1,300M is sequentially DOWN from $1,329M; if AI chip capex plateaus, ATE orders can swing 20–40% peak-to-trough and the 32.9% OM compresses hard.
- Hyperscaler concentration — ATE demand is hyperscaler-AI-capex-driven (Google TPU, Amazon Trainium, Microsoft Maia, NVIDIA GB-series); a single hyperscaler capex pause hits Semi Test directly.
- Cobot leg dilution — if UR cannot defend ASPs against Chinese competitors, the "physical-AI actuation" thesis (7.5% of revenue) shrinks further.
- Humanoid displacement — if humanoids (Figure, 1X, Boston Dynamics) displace fixed cobot arms in manufacturing, UR's installed base is at risk.
Hypothesis verdict: INTACT — The ATE leg is firing (record revenue, duopoly pricing, operating leverage) and validates TER as the AI-semicap quality gate; the robotics leg is a dormant call option. Verdict stays INTACT (not STRENGTHENED) because Q3 guidance is sequentially down and the "physical-AI actuation" half of the dual thesis has not inflected. DB writeback this pass: ts 7 / ec 7 / ttm 6 (integers, from legacy 6.0/7.0/4.0); toll-road unchanged at 8 DIRECT BOTTLENECK.
Named Semi Test competitors: Advantest, SPEA, Cohu (FY2025 10-K). CPO insertions split Advantest / TER / a Taiwanese handler-aligner (GS 2026-09-09). Robotics: KUKA, ABB, FANUC, Staubli, Yaskawa (industrial); Techman, Doosan, Jaka, AUBO (cobot); Omron, Rockwell, HikRobot, KION (AMR). Internal customer supply is an explicit 10-K risk.
- Q3 sequential digest becomes a downcycle. Guide $1,200–1,300M vs Q2 $1,329M. If Q4/Q1 do not re-accelerate, the 32.9% OM compresses the way ATE always does (FY2025 OM was 20.4%).
- Test intensity mean-reverts to ~4% of CapEx. That cuts the 2028–30 TAM from $20–24B to $10–12B even if WFE hits $250B.
- Merchant-compute conversion stalls below 30%. The 2027 volume print is the binary; a 2027 10-Q that still shows "small fleet" is a miss.
- Customer concentration. One additional direct customer = 19% of FY2025; two specifiers 12% and 10%; top-5 44%. One VIP/hyperscaler pause is a mid-teens revenue hole.
- Robotics stays pretax-negative even through the 2027 3x print — then the Layer 8 option never pays for itself.
- Copper / NPO displaces CPO. Smith himself flagged copper scale-up and NPO as yield-risk hedges that shrink the CPO test TAM.
- 2026-09-09 GS Communacopia fireside (CEO Greg Smith): 4%→8% test/CapEx, 2027 merchant-compute + 2nd hyperscaler share, CPO TAM path, robotics 3x/3x, GM 59–61% hold, OpEx growth < 1/2 revenue growth. Next earnings estimated 2026-10-27.
- 2026-08-07/10 8-K: $1.0B 5-year senior secured revolver; $0 drawn at signing.
- 2026-07-28/31 Q2 print + 10-Q: record $1,329M, Semi Test $1,122M, Robotics +33.4% YoY.
- 2026-04-08 MLTP JV closed (75% / $157.8M) — 10-Q Note D; results in Product Test.
Thesis-level disconfirmation would include:
- Semiconductor Test share loss: Teradyne’s semiconductor test revenue or orders decline while Advantest reports growth in comparable segments over the same period. This would undermine the market-position thesis.
- No AI-driven test intensity increase: If Teradyne’s own 10-K/10-Q shows compute/SoC test demand growing slower than semiconductor unit growth, then the “complexity drives test spending” thesis fails.
- Robotics margin failure: If the Robotics segment’s operating margin remains persistently low or negative despite revenue recovery, the sum-of-parts bull case weakens materially.
- Customer concentration risk realized: If a major customer cuts or delays test purchases and Teradyne’s backlog declines sharply, the cyclical risk outweighs the switching-cost argument.
- Gross margin compression: If gross margin falls below its historical range because of pricing competition from Advantest or lower utilization, earnings power estimates would need to be revised down.
- Competitor design-win disclosures: If Advantest or Cohu filings show major design wins at Teradyne accounts, the assumed switching-cost barrier may be weaker than modeled.
This section states what would weaken or invalidate a Teradyne moat/cyclical-recovery thesis:
- No switching-cost protection in reality. If the 10-K or customer disclosures show that semiconductor test customers routinely dual-source or replace tester platforms without major engineering cost, the moat argument weakens sharply.
- Segment margin compression. If Semiconductor Test gross margin falls below historical norms and remains low while revenue declines, Teradyne has lost pricing power, not merely suffered a downcycle.
- Robotics dilution. If Robotics revenue grows but segment operating margin remains negative or low, the diversification thesis fails; growth would be dilutive rather than accretive.
- Advantest gains share. If Advantest’s primary filings show faster comparable semiconductor-test revenue growth, higher R&D intensity, or explicit share claims that contradict Teradyne’s positioning, a “leader” thesis is false.
- Memory-test structural loss. If Teradyne is structurally losing high-volume memory test sockets to Advantest or in-house solutions, Semiconductor Test growth will underperform sector recovery.
- Customer concentration increases. If the 10-K discloses rising dependence on a few large customers, Teradyne’s revenue becomes more volatile than the segment mix suggests.
- Channel inventory in robotics. If robotics sell-through to end users weakens while reported revenue is buoyed by distributor stock builds, the apparent robotics growth is not real demand.
- Accounting/quality flags. Any material weakness, restatement, unusual warranty/reserve changes, or aggressive revenue-recognition change in the 10-K would disconfirm a clean financial-quality assumption.
- Tester ASP decline. If average selling prices for semiconductor test systems decline persistently, the switching-cost unit economics may remain, but the profit pool shrinks.
- Macro/semiconductor capex stall. If wafer-fab equipment and OSAT test capex remain depressed for multiple quarters, the cyclical recovery assumption fails.
The thesis that Teradyne is a quality business with sticky ATE and optionality in robotics would be wrong if:
- Semiconductor test demand drops sharply — if leading-edge SoC test orders slip or customers delay capacity additions, Teradyne’s Semiconductor Test revenue and margin would decline.
Test: Watch quarterly Semiconductor Test segment revenue against the prior year and against Advantest disclosures.
- Competitive share loss to Advantest in SoC test — if Advantest’s V93000-class platforms gain at Teradyne’s strongest customers, especially in high-performance compute or mobile, the competitive moat would be weaker than assumed.
Test: Compare Teradyne and Advantest segment revenue growth, especially SoC/system-level test.
- Industrial Automation permanently compresses margins — if Universal Robots and MiR continue to dilute corporate margin without reaching acceptable scale, the robotics segment may erode overall returns.
Test: Pull segment operating income/margin for Industrial Automation from the 10-K.
- Customer concentration worsens — if the top five customers rise materially above historical levels, Teradyne could bear pricing or volume risk if one customer shifts to Advantest or reallocates capital.
Test: Read the 10-K customer-concentration risk factor for disclosure of top-five/top-one percentages.
- The switching-cost assumption is wrong — if programmable test programs have become more portable, or if customers increasingly dual-source and re-qualify testers cheaply, the switching-cost moat would be weaker.
Test: Examine customer procurement behavior, dual-sourcing commentary, and competitor win rates.
- Valuation/expectations mismatch — even if the business is sound, paying too high a price can invalidate the investment. This note does not calculate valuation, but a stock-price drawdown alone does not make the company cheap.
The thesis would be weakened or invalidated if any of the following appear in subsequent filings:
If Teradyne’s semiconductor test revenue declines faster than the semiconductor equipment industry, or if Advantest reports sustainable share gains in high-end SoC test, then the core business’s competitive moat is weaker than assumed.
Evidence to look for:
- Teradyne Semiconductor Test segment revenue growth vs. Advantest SoC tester segment growth.
- Customer testimonial shifts to Advantest V93000 for AI accelerator test.
- Teradyne gross margin falling below, say, 52–54% with no revenue recovery.
If order growth does not inflect after customer inventory normalization, the cyclical thesis is wrong. High-fixed-cost leverage would continue to compress operating margins.
If a large customer standardizes on a new test platform despite incumbent Teradyne programs, then test-program portability is higher than assumed and switching cost declines.
If industrial automation/robotics revenue remains a low-growth, low-margin segment, the optionality thesis fails. The robotics segment is less defensible than semiconductor test because there are many credible competitors.
If any one customer, foundry, or OSAT accounts for 10%+ of revenue and delays purchases, revenue could fall sharply. Validate the 10-K customer concentration note.
If semiconductor test pricing becomes more competitive and gross margin declines without a revenue rebound, that would contradict the pricing-power assumption.
If AI/HPC test demand is real but Advantest captures most of it, Teradyne’s semiconductor test franchise would be structurally disadvantaged.
The following would materially weaken the bullish or business-quality thesis on Teradyne:
- Sustained semiconductor test order decline beyond normal cyclicality. If Teradyne’s orders do not stabilize while competitor orders grow, it suggests share loss, not just cycle weakness.
- Gross margin falls below ~50% GAAP and stays there. This would suggest pricing power is eroding, likely from Advantest competition or customer concentration.
- Loss of a key IDM or OSAT platform qualification. If a major customer shifts its next-generation device test from UltraFLEX to Advantest V93000 or another platform, Teradyne’s long-term revenue stream is threatened.
- Robotics segment fails to scale or returns to persistent operating losses. Robotics diversification would then be a drag rather than a growth engine.
- A direct competitor filing showing Teradyne lost market share. If Advantest’s semiconductor test revenue grows faster than Teradyne’s in the same period, the “market leader” narrative fails.
- Service attach declines. Falling service revenue as a percentage of product revenue indicates lower installed-base stickiness and weaker recurring economics.
- Customer concentration emerges or rises above 10%. A newly disclosed 10% customer would increase revenue dependency and reduce negotiating power.
- Technology disruption in test. If chiplets, silicon photonics, or advanced packaging shift test requirements to a new architecture where Teradyne lacks a competitive platform, incumbent advantage weakens.
- Balance-sheet deterioration. A large acquisition funded with debt, or a sharp decline in cash and marketable securities, would reduce strategic optionality.
- Any evidence in SEC filings of channel stuffing, aggressive revenue recognition, or inventory build at customers. This would suggest reported revenue is not backed by end demand.
- What percentage of semi test revenue is now AI/HBM-specific vs legacy consumer/mobile SoC — and is HBM test demand still accelerating or stabilizing in Q2 2026?
- Is UR cobot revenue re-accelerating in H1 2026 as manufacturing capex recovers from the 2023-24 cycle trough? What is the book-to-bill for UR?
- Has Teradyne disclosed any ATE programs specific to humanoid robot motor/actuator test — could ATE expand to test physical AI hardware beyond chips?
- What is the threat timeline for Chinese cobot vendors (Jaka, Aubo) gaining Western EU/US market share vs UR's ecosystem moat?
- Does the Q3 FY2026 10-Q (print ~2026-10-27) show merchant-compute still "small fleet" or first volume?
- Robotics pretax: does the 63.7% incremental conversion take the segment through breakeven in 2H26 / 2027?
- MLTP / Quantifi contribution to Product Test — 10-Q does not break out; need FY2026 10-K.
- Technology note for semiconductor ATE / KGD is missing in the vault — queued for Sunday Technology Deep Research.
INTACT — both the ATE (AI chips) and robotics (cobots) legs of the thesis remain valid. However conviction is capped at 3/5 due to cyclical risk in ATE and cobot competitive pressure. The strong +8.29% absolute return (+17pp alpha) confirms the thesis is working but valuation (fwd P/E ~55x) limits further upside without earnings beats.
INTACT — Both the ATE (AI chip test quality gate) and UR cobot (Physical AI deployment platform) legs of the thesis remain valid and delivering positive alpha. Conviction capped at 3/5 per existing vote due to: (a) ATE cyclicality risk, (b) UR competitive pressure from Chinese cobots, (c) no single concentrated bottleneck like POWL's 85-week lead time. The +8.29% / +17pp alpha confirms the thesis is tracking well. Watch for HBM test demand data in next earnings.
Sources
35 sources preserved from the latest qualified research update.
- sec.govTeradyne FY2025 Form 10 KOpen source ↗
- sec.govTeradyne SEC EDGAR filingsOpen source ↗
- sec.govSEC 8 K EX 99.1 Q2 FY2026Open source ↗
- data.sec.govdata.sec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- investing.cominvesting.comOpen source ↗
- investors.teradyne.cominvestors.teradyne.comOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- data.sec.govdata.sec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- investors.teradyne.cominvestors.teradyne.comOpen source ↗
- semiconductors.orgsemiconductors.orgOpen source ↗
- wsts.orgwsts.orgOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- advantest.comadvantest.comOpen source ↗
- data.sec.govdata.sec.govOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- advantest.comadvantest.comOpen source ↗
- sec.govsec.govOpen source ↗
- sec.govsec.govOpen source ↗
- investors.teradyne.cominvestors.teradyne.comOpen source ↗
- semi.orgsemi.orgOpen source ↗
- sec.govsec.govOpen source ↗
Teradyne (TER) Stock: ATE + Cobot Dual Thesis for Physical AI
894 words · Research as of 21 Jul 2026
Preserved research context: this long-form synthesis reflects the evidence and valuation snapshot available on 21 Jul 2026. Use the current snapshot above for the latest signal, conviction, target and market-cap values.
Investment Thesis
Teradyne (TER) is a dual picks-and-shovels play on the Physical AI supercycle, spanning two structurally distinct but thematically aligned businesses. On one side, Teradyne's semiconductor test equipment (ATE) is the quality gate for every AI chip, HBM memory stack, and custom ASIC—no AI processor enters a data center without passing through a Teradyne tester. On the other, its Universal Robots (UR) subsidiary is the global leader in collaborative robots (cobots), deploying the physical actuation layer of AI directly onto factory floors. The thesis is simple: as AI moves from the data center into the physical world, demand for both the chips that run it and the robots that execute it grows—and Teradyne collects tolls at both gates.
At $427.32 (July 2026), the stock has returned +14.84% since its June 2 flag with +30.20pp alpha versus the BOTZ robotics ETF. The dual thesis is outperforming even as the robotics sector broadly underperforms.
Physical AI / Value-Chain Relevance
Teradyne sits at two distinct layers of the Physical AI value chain simultaneously—an unusual structural advantage that few companies in the universe share.
Layer 4–6 (Edge Compute / Real-Time Control & Safety) via ATE: Every AI chip—from NVIDIA Hopper and Blackwell GPUs to Google TPU v5, Amazon Trainium3, and Microsoft Maia—must be tested at wafer sort and final package test. Teradyne's UltraFLEX+, J750, and Magnum platforms are the dominant test infrastructure across SoCs, memory, and mixed-signal devices. The HBM3E memory stacks that feed AI accelerators require Teradyne's Magnum EPIC platform for high-parallelism burn-in and functional test. This is not optional capex; it is a hard quality gate baked into every chip's production flow. HBM test demand grew more than 30% year-over-year in FY2025 as AI memory volume ramped.
Layer 7 (Actuation & Motion Control) via Universal Robots: UR holds roughly 40–50% of the global collaborative robot market by unit shipments, with more than 75,000 cobots deployed and a certified integrator network of 1,000+ partners. The UR+ application ecosystem—100,000+ URCap plugins—creates a two-sided market moat: the more integrators build on the UR platform, the more valuable the platform becomes to end customers. UR cobots are deployed in light assembly, machine tending, pick-and-place, quality inspection, and logistics across automotive, electronics, life sciences, and general manufacturing.
Crossing both layers, Teradyne benefits from AI-chip volume (ATE) and physical AI deployment (UR cobots) simultaneously—a positioning that no single-layer pure-play can replicate.
Catalysts
- HBM test demand acceleration: HBM3E ramp for NVIDIA GB200 and next-generation AI accelerators directly drives Magnum EPIC platform revenue. Continued AI memory bandwidth scaling (HBM4 on the horizon) extends this multi-year cycle.
- UR cobot adoption reacceleration: Manufacturing capex is recovering from the 2023–24 cycle trough, and UR's installed base growth has historically tracked industrial automation investment. Early evidence suggests UR revenue growth reaccelerating in H1 2026 as factories add automation capacity for reshoring and labor substitution.
- Custom AI ASIC proliferation: The shift toward in-house AI silicon at hyperscalers (Google, Amazon, Microsoft, Apple, Meta) expands the addressable ATE market beyond merchant semiconductor customers. Each custom ASIC needs Teradyne's test platforms.
- MiR AMR expansion: Mobile Industrial Robots (MiR), Teradyne's autonomous mobile robot subsidiary, is growing ~20% YoY as warehouse and factory intralogistics automation accelerates—a complementary growth vector to UR.
Positioning / What the Market May Be Missing
The market tends to value Teradyne as either a semicap cyclical (ATE) or a robotics OEM (UR), rarely grasping the compound diversification benefit. When semi test orders slow, UR growth provides offset; when robotics capex pauses, AI chip test demand drives ATE. This is not merely diversification—it is structural hedging across two independently growing end-markets tied to the same Physical AI supertheme.
More importantly, the ATE installed base creates switching costs that are enormously underappreciated. Once a fab or OSAT qualifies a product on a Teradyne platform, switching vendors requires 12–18 months of test program redevelopment and revalidation at $1–2M+ per product tape-out. This is a golden handcuff: customers leave only when compelled by generational technology shifts.
Risks and What Invalidates the Thesis
- ATE cyclicality: Semiconductor test is notoriously cyclical. A peak-to-trough revenue swing of 30–40% is normal in this industry. If AI chip capex pauses or consumer SoC demand softens, ATE orders can collapse in one to two quarters.
- Chinese cobot competition: Jaka, Aubo Robotics, and Doosan are selling cobots at 20–40% discounts to UR in Asia-Pacific and increasingly in Europe. ASP compression is a real margin risk to the robotics segment.
- Humanoid displacement risk: If humanoid robots (Figure, 1X, Agility) displace collaborative arms in manufacturing workflows over a 3–5 year horizon, UR's $15k–$30k arm could face structural demand erosion.
- Valuation de-rate: At fwd P/E ~63x (and trailing P/E ~80x), the stock prices significant growth. Any growth deceleration triggers multiple compression.
What to Watch Next
- Q2 2026 earnings: ATE segment book-to-bill ratio and HBM test revenue share specifically. A book-to-bill below parity warns of cyclical softening.
- UR revenue growth rate: Sequential UR revenue growth above 15% YoY confirms manufacturing capex recovery is real. Below 10% suggests headwinds from Chinese competition.
- MiR order trajectory: Watch for large warehouse automation deals (e.g., Amazon, Walmart, DHL) that signal AMR adoption at scale.
- HBM4 test program wins: Teradyne's design-in status for next-generation HBM memory test (HBM4, expected 2026–2027) is a multi-year lead indicator.